Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chemotherapy-induced extracellular matrix remodelling in HGSOC

ABSTRACT: In this study we used two murine orthtotopic, transplantable synegeneic models, one that displays excellent response (60577) to carboplatin/paclitaxel and one that is highly chemoresistant (HGS2) and displays a weak response. We analysed the transcriptomes of these murine HGSOC tumours from both models across time in a therapeutic scheme that resembles the human condition.

ORGANISM(S): Mus musculus

PROVIDER: GSE270878 | GEO | 2026/01/14

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Chemotherapy induced dynamic gene expression changes in vivo are prognostic in ovarian cancer

Project description:Carboplatin and paclitaxel are the most widely prescribed chemotherapeutic agents for ovarian cancer. Not all patients respond to treatment, so there is a need for biomarkers that reliably predict resistance in ovarian tumors. Expression of such biomarkers may be dynamically controlled. Gene expression was assessed for a period of 14 days after treatment with carboplatin or combined carboplatin-paclitaxel in xenografts from two ovarian cancer models: chemosensitive serous adenocarcinoma derived OV1002 and slow growing, chemoresistant HOX424 of clear cell origin. Tumour volume reduction was observed in both cell lines post treatment, with a more prominent effect in OV1002, which subsided in late time points. In OV1002, hierarchical clustering classified differentially expressed genes into four time-related patterns, upregulated and downregulated groups for each early and late expressed genes. Upregulated genes were involved in DNA repair, cell cycle and apoptosis, while downregulated groups were involved in oxygen consuming metabolic processes and apoptosis control. Carboplatin-paclitaxel treatment triggered a more comprehensive response. HOX424 responded only to the combined treatment, while the observed reduction in tumour growth was limited. Several apoptosis and cell cycle genes were upregulated, while Wnt signaling was downregulated in the exclusively late expression pattern observed in this cell line. Late downregulated gene groups post carboplatin-taxane treatment were capable of predicting overall survival in two independent clinical datesets. Pathways overrepresented in these clusters were also predictive of outcome. This longitudinal gene expression study may help characterization of chemotherapy response, identification of resistance biomarkers and guiding timing of biopsies. 101 samples from 2 cell lines, untreated, carboplatin (Carbo) treated, carboplatin-paclitaxel (Carbotax) treated, over 5 time points (days 1,2,4,7,14)

2014-06-16 | E-GEOD-49577 | biostudies-arrayexpress

Tri-cultures of HGSOC cells replicate tissue remodelling observed in biopsies.

Project description:We built novel tri-cultures of HGSOC cells with human primary omental adipocytes and fibroblasts which replicated tissue remodelling and matrisome production observed in biopsies. RNAseq analysis showed that tri-cultures reproduced the prognostic matrisome signature.

2020-01-01 | GSE125109 | GEO

RNA-seq of FFPE-macrodissected HGSOC tissues and solid and ascites-derived HGSOC 2D cultures

Project description:Stratification of a retrospective cohort of HGSOC based on its tissues of origin.

2020-09-29 | E-MTAB-9605 | biostudies-arrayexpress

Chemotherapy induced dynamic gene expression changes in vivo are prognostic in ovarian cancer

2014-06-16 | GSE49577 | GEO

Tri-cultures of HGSOC cells replicate tissue remodelling observed in biopsies.

Project description:Tri-cultures of HGSOC cells replicate tissue remodelling observed in biopsies.

| PRJNA515261 | ENA

RNA sequencing of pre-treatment biopsy sampless from BrighTNess phase III study (AFT-04)

Project description:BrighTNess was a phase III, multicenter, randomized, double-blind, placebo-controlled study that enrolled stage II/III TNBC patients to receive neoadjuvant chemotherapy with paclitaxel followed by doxorubicin/cyclophosphamid (AC), or the same plus carboplatin or carboplatin plus the PARP inhibitor veliparib concurrent with paclitaxel. Whole transcriptome RNA sequencing (RNAseq) was performed on pre-treatment research biopsies.

2021-01-08 | GSE164458 | GEO

RNA-seq of FFPE-macrodissected HGSOC tissues and solid and ascites-derived HGSOC 2D cultures

Project description:RNA-seq of FFPE-macrodissected HGSOC tissues and solid and ascites-derived HGSOC 2D cultures

| PRJEB40519 | ENA

Single-cell RNA sequencing samples from high-grade serous ovarian cancer (HGSOC)

Project description:We measured gene expression in single-cell RNA sequencing samples from patients with high-grade serous ovarian cancer (HGSOC), for a study on improving HGSOC subtype definition by taking into account varying cell type proportions within tumors.

2020-10-03 | GSE158937 | GEO

Gene expression in High-Grade Serous Ovarian Cancer (HGSOC) cells

Project description:Gene expression in High-Grade Serous Ovarian Cancer (HGSOC) cells

2024-12-31 | GSE214904 | GEO

Copy number analysis in melanoma tumor samples from E2603

Project description:Blinded study, melanoma tumor samples from patients treated with carboplatin and paclitaxel +/- sorafenib are compared aCGH of human melanoma tumor samples

2015-10-10 | GSE73899 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data